A mutant virus is provided which contains a mutation at a phosphorylation site in one or more of the proteins of the virus, which mutation causes the virus to be attenuated, and therefore, an improved vaccine composition can be produced therewith. The glucose concentration is indicative of the subject’s immediate glycemic condition, whereas the protein-bound glucose concentration is indicative of either intermediate or long-term glycemic condition. A support element is located in the gas outlet aperture with a sealing element next to the side of the support element that faces the interior of the vessel.